OR WAIT null SECS
© 2023 MJH Life Sciences and Consultant Live. All rights reserved.
December 16, 2022
With several newly approved therapies hitting the market and an overflowing pipeline, the FDA has stepped in to help keep the burgeoning world of biotech on track.
November 23, 2022
The BLA was supported by positive data from 54 patients with hemophilia B in the pivotal phase 3 HOPE-B trial.
August 17, 2022
“The approval of ZYNTEGLO marks a watershed moment for the field of gene therapy," Andrew Obenshain, CEO of Bluebird Bio says.
February 28, 2022
Clinical and industry leaders share their perspectives on the importance of collaboration in developing treatments for rare diseases.